Timothy Compton

Timothy Compton

Avid Bioservices Inc. (Nasdaq: CDMO) named Timothy Compton chief commercial officer.

He replaces Tracy Kinjerski, who’s left the contract drug maker.

Get the latest OC business and Coronavirus updates

Compton was previously senior director of sales at Cambrex Corp., a contract maker of small molecules.

For more on Avid’s growth plans and its recent executive shifts, see the Jan.27 print edition of the Business Journal.